Guatemala - Tiếng Tây Ban Nha - Ecolab

ecolab deutschland gmbh -

Canada - Tiếng Tây Ban Nha - Ecolab

ecolab deutschland gmbh -

Costa Rica - Tiếng Tây Ban Nha - Ecolab

ecolab deutschland gmbh -

Cuba - Tiếng Tây Ban Nha - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

empresa laboratorio farmacÉutico lÍquidos orales, medilip, bayamo, cuba. - gotas orales

Liên Minh Châu Âu - Tiếng Tây Ban Nha - EMA (European Medicines Agency)

accord healthcare s.l.u. - lenalidomida - mieloma múltiple - inmunosupresores - multiple myelomalenalidomide accord as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide accord as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) está indicado para el tratamiento de pacientes adultos no tratados previamente con mieloma múltiple que no son elegibles para el trasplante. la lenalidomida acuerdo en combinación con dexametasona está indicado para el tratamiento de mieloma múltiple en pacientes adultos que han recibido al menos una terapia previa. follicular lymphomalenalidomide accord in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Peru - Tiếng Tây Ban Nha - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

inretail pharma s.a. - droguerÍa - tableta - por vial - - otras combinaciones de multivitaminas

Peru - Tiếng Tây Ban Nha - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

inretail pharma s.a. - droguerÍa - tableta masticable - por tableta - - otras combinaciones de multivitaminas

Cuba - Tiếng Tây Ban Nha - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

empresa laboratorio farmacéutico líquidos orales, medilip. - clorhidrato de tiamina; nicotinamida; vitamina a (eq. a 5 000 ui de vitamina a que equivalen a 5 mg de palmitato de retinol en aceite); ergocalciferol (eq. a 400 ui de vitamina d2); 5 fosfato sódico de riboflavina - gotas orales - 1,5 mg/ml; 0,01 mg/ml; 2 mg/ml; 4,1 mg/ml; 20 mg/ml

Liên Minh Châu Âu - Tiếng Tây Ban Nha - EMA (European Medicines Agency)

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - agentes antineoplásicos - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

Liên Minh Châu Âu - Tiếng Tây Ban Nha - EMA (European Medicines Agency)

mylan ireland limited - lenalidomida - mieloma múltiple - inmunosupresores - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).